Motility-related protein 1 (MRP-1/CD9) expression in urothelial bladder carcinoma and its relation to tumor recurrence and progression

This publication has 21 references indexed in Scilit:

• E-cadherin expression in urothelial carcinoma in situ, superficial papillary transitional cell carcinoma, and invasive transitional cell carcinoma
  Human Pathology, 2002
• Contemporary Management Of Stage T1 Transitional Cell Carcinoma Of The Bladder
  Journal of Urology, 2002
• Diagnosis and management of superficial bladder cancer
  Current Problems in Cancer, 2001
• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• Relationship of Cytokeratin 20 and CD44 Protein Expression with WHO/ISUP Grade in pTa and pT1 Papillary Urothelial Neoplasia
  Laboratory Investigation, 2000
• THE NATURAL HISTORY OF BLADDER CANCER
  Urologic Clinics of North America, 2000
• RECURRENCE AND PROGRESSION IN LOW GRADE PAPILLARY UROTHELIAL TUMORS
  Journal of Urology, 1999
• Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA.
  The Journal of Experimental Medicine, 1993
• NATURAL HISTORY OF SUPERFICIAL BLADDER CANCER
  Urologic Clinics of North America, 1992
• Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility.
  The Journal of Experimental Medicine, 1991